Total Payments
$2,187
2024 Payments
$110.57
Companies
19
Transactions
102
Medicare Patients
23,503
Medicare Billing
$5.2M
Payment Breakdown by Category
Food & Beverage$2,139 (97.8%)
Education$47.95 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,139 | 101 | 97.8% |
| Education | $47.95 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $772.84 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $437.35 | 19 | $0 (2023) |
| Genentech USA, Inc. | $185.27 | 6 | $0 (2020) |
| Allergan, Inc. | $139.79 | 6 | $0 (2022) |
| Biofrontera Inc. | $105.62 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $86.12 | 5 | $0 (2024) |
| Amgen Inc. | $72.06 | 2 | $0 (2018) |
| Galderma Laboratories, L.P. | $67.66 | 3 | $0 (2021) |
| Lilly USA, LLC | $56.77 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $52.38 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.57 | 7 | E.R. Squibb & Sons, L.L.C. ($46.78) |
| 2023 | $219.88 | 10 | Lilly USA, LLC ($45.88) |
| 2022 | $221.94 | 13 | ABBVIE INC. ($169.99) |
| 2021 | $192.93 | 12 | AbbVie Inc. ($63.68) |
| 2020 | $156.96 | 8 | Genentech USA, Inc. ($47.95) |
| 2019 | $185.43 | 5 | AbbVie, Inc. ($112.44) |
| 2018 | $488.83 | 17 | Novartis Pharmaceuticals Corporation ($176.27) |
| 2017 | $610.45 | 30 | AbbVie, Inc. ($223.89) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Dermatology | ||||||
| 05/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.92 | General |
| Category: Immunology | ||||||
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Immunology | ||||||
| 01/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.04 | General |
| Category: Immunology | ||||||
| 12/19/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 11/01/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Immunology | ||||||
| 10/25/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.48 | General |
| Category: DERMATOLOGY | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.46 | General |
| 05/24/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $45.88 | General |
| Category: Immunology | ||||||
| 05/23/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/18/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 01/04/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Dermatology | ||||||
| 11/30/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.98 | General |
| Category: Immunology | ||||||
| 11/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.39 | General |
| 10/12/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $70.38 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 5,193 | 17,764 | $1.6M | $1.2M |
| 2022 | 38 | 5,840 | 20,756 | $1.9M | $1.4M |
| 2021 | 36 | 6,110 | 21,175 | $1.9M | $1.4M |
| 2020 | 33 | 6,360 | 20,248 | $1.8M | $1.3M |
Total Patients
23,503
Total Services
79,943
Medicare Billing
$5.2M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 112 | 1,934 | $467,096 | $372,285 | 79.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 943 | 3,570 | $242,147 | $180,997 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 763 | 1,398 | $119,549 | $80,939 | 67.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 146 | 176 | $112,627 | $65,972 | 58.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 520 | 1,769 | $82,441 | $64,301 | 78.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 673 | 1,009 | $94,689 | $63,573 | 67.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 121 | 154 | $59,178 | $46,270 | 78.2% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 109 | 128 | $52,458 | $41,406 | 78.9% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 112 | 1,333 | $48,464 | $38,875 | 80.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 65 | 84 | $50,522 | $37,010 | 73.3% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 35 | 38 | $32,681 | $24,834 | 76.0% |
| 17283 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 100 | 155 | $35,308 | $21,943 | 62.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 345 | 4,417 | $27,595 | $21,072 | 76.4% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 114 | 184 | $32,952 | $18,948 | 57.5% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 44 | 64 | $23,647 | $18,755 | 79.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 439 | 683 | $42,807 | $18,558 | 43.4% |
| 17273 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 66 | 97 | $19,013 | $10,803 | 56.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 162 | 162 | $17,117 | $10,271 | 60.0% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 14 | 29 | $11,337 | $8,888 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 89 | $10,695 | $7,160 | 66.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 15 | 30 | $7,587 | $5,538 | 73.0% |
| 69100 | Biopsy of ear | Office | 2023 | 93 | 122 | $10,961 | $4,604 | 42.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 26 | 26 | $12,096 | $4,470 | 37.0% |
| 17264 | Destruction of cancer skin growth of trunk, arms, or legs, 3.1-4.0 cm | Office | 2023 | 18 | 24 | $4,612 | $2,930 | 63.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,476 | $1,684 | 68.0% |
About Dr. Michael Crowe, M.D
Dr. Michael Crowe, M.D is a Dermatology healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477667038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Crowe, M.D has received a total of $2,187 in payments from pharmaceutical and medical device companies, with $110.57 received in 2024. These payments were reported across 102 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,139).
As a Medicare-enrolled provider, Crowe has provided services to 23,503 Medicare beneficiaries, totaling 79,943 services with total Medicare billing of $5.2M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Dermatopathology
- Location Owensboro, KY
- Active Since 08/19/2006
- Last Updated 02/24/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1477667038
Products in Payments
- COSENTYX (Biological) $356.84
- Humira (Biological) $272.69
- Erivedge (Biological) $185.27
- RINVOQ (Biological) $171.04
- SKYRIZI (Biological) $101.35
- Sotyktu (Drug) $86.12
- Enbrel (Biological) $72.06
- ACZONE (Drug) $67.94
- Ameluz (Drug) $64.00
- TALTZ (Drug) $56.77
- HUMIRA (Biological) $54.07
- ENSTILAR (Drug) $49.54
- DUPIXENT (Biological) $41.72
- AMELUZ (Drug) $41.62
- AKLIEF (Drug) $39.99
- DUOBRII (Drug) $31.11
- BOTOX (Biological) $29.27
- BOTOX COSMETIC (Biological) $27.72
- TREMFYA (Drug) $24.04
- COSENTYX (Drug) $19.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Owensboro
Dr. Artis Truett, M.d, M.D
Dermatology — Payments: $23,260
Dermatology $23,260
Sandra Cox, Arnp, ARNP
Dermatology — Payments: $4,599
Dermatology $4,599
Dr. Cassey Vessels, M.d. (May 2008), M.D. (MAY 2008)
Dermatology — Payments: $2,248
Dermatology $2,248
Dr. Nicole Brey, M.d, M.D
Dermatology — Payments: $949.53
Dermatology $949.53